Le Lézard
Classified in: Health
Subject: PER

Sanda Morar, M.D. Joins The Oncology Institute of Hope and Innovation


CERRITOS, Calif., Sept. 19, 2018 /PRNewswire-PRWeb/ -- Dr. Morar is a graduate of the the University Of Medicine and Pharmacy, Carol Davilla in Bucharest, Romania. She completed her advanced medical training with a residency at the Ohio Valley Medical Center, followed by a fellowship in medical oncology at the Allegheny Health Network, in Pittsburgh, PA.

Dr. Sanda Morar has spent nearly three decades serving as a physician, with more than 19 years of experience in the medical oncology field. She has built a reputation as a patient-centered oncologist with a particular interest in breast, colon, and gynecological cancers. Dr. Sanda Morar recently completed her assignment as a medical oncologist with the Morrison Cancer Center in Hastings, Nebraska. She was the Medical Director for the Virginia Piper Cancer Institute at the Cambridge Medical Center in Cambridge, Minnesota. She also served as chair of the Institute's Oncology Committee and as a Cancer Liaison. Prior to her work with the Virginia Piper Cancer Institute, Dr. Sanda Morar led as Director of Oncology at Minnesota Oncology ( Cambridge Medical Center Cancer program) - a role in which she worked with approximately 18 cancer patients a day while maintaining her involvement in clinical trials. She also has experience as a medical oncologist for Mid-Illinois Hematology and Oncology Associates.

She is highly active in clinic development and clinical trials and is fluent in Romanian.

Patient Care Philosophy:
Dr. Morar believes strongly in educating her patients. She believes that is key for patients being able to manage their own healthcare. She customizes her care to reflects her patient's needs, their values and their choices.

 

SOURCE The Oncology Institute


These press releases may also interest you

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...

at 00:00
Health Carousel, renowned for its dedication to enhancing the healthcare staffing sector, today unveiled its groundbreaking 'Full Circle of Support' program. This initiative represents a significant investment in the total well-being of its...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...

17 avr 2024
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...

17 avr 2024
Scottie Resources Corp. ("Scottie" or the "Company") announces that it has granted 7,400,000 options to acquire common shares to certain directors, officers, and consultants to the Company. The options are exercisable at a price of $0.195 per...

17 avr 2024
DaVita Inc. , announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is...



News published on and distributed by: